Inhalation Sciences appoints new Chief Commercial Officer to drive global sales
Inhalation Sciences (ISAB) has appointed Paolo Raffaelli as its new Chief Commercial Officer (CCO). Mr Raffaelli has extensive experience driving international sales in a wide range of medical device companies and takes up his position on December 14, 2020.The new CCO will be responsible for driving ISAB sales in Europe, the US and other international markets. He will have overall responsibility for Sales and Marketing activities, with a primary focus on account targeting.Paolo Raffaelli has over 20 years’ executive experience in the life science and medical device industry, with